Company intelligence / Profile preview

CCBR Clinical Research

Stans, Nidwalden, Switzerlandccbrballerup.webvent.tv ↗

Ownership: Private
Employees: ~77
Development stage: Other

Overview

CCBR Clinical Research is a global network of clinical development and research clinics specializing in subject recruitment and the design and conduct of clinical trials for pharmaceutical and biotechnology industries. The company has managed over 30 clinical trials with more than 1500 subjects randomized across a wide range of therapeutic areas. Its most advanced known program is balaglitazone for type 2 diabetes, which reached Phase 3.

Therapeutic areas: Endocrinology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Nordic Bioscience A/SDr. Reddy's Laboratories Ltd.

Beyond the preview

Go deeper on CCBR Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCBR Clinical Research.

Explore the full profile